Literature DB >> 10879227

Cytological analysis of breast lesions: a review of 780 cases.

G Jayaram1, S F Alhady, C H Yip.   

Abstract

780 breast cytology samples obtained over a one year period at the Breast Clinic of the University Hospital, Kuala Lumpur were reviewed. These included 745 fine needle aspirates (FNA's) and 35 nipple smears. The broad categories of cytodiagnoses were as follows: malignant: 95, suspicious or equivocal: 26, benign: 543, no proliferative lesion: 58 and inadequate: 58. The benign and malignant lesions were also subcategorized on cytological basis. The suspicious or equivocal lesions were subjected to biopsy and 17 of these proved to be malignant. 194 cases that were subjected to histological confirmation and 34 cases that were considered to be undisputably malignant (on the basis of clinical features, recurrences, metastases, etc.) were subjected to statistical analysis (total 228 cases). If the cytologically suspicious/equivocal category was considered as "test positive" the sensitivity of cytodiagnosis was 97.4% and the specificity 92%. The high degree of cytodiagnostic sensitivity and specificity make breast cytology a valuable adjunct in the evaluation of breast lesions.

Entities:  

Mesh:

Year:  1996        PMID: 10879227

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  2 in total

1.  Comparison of ultrasonography and fine needle aspiration cytology in the diagnosis of malignant breast lesions.

Authors:  Yumjaobabu Singh Takhellambam; Sunil Singh Lourembam; Opendro Singh Sapam; Raju Singh Kshetrimayum; Bhubon Singh Ningthoujam; Tousif Khan
Journal:  J Clin Diagn Res       Date:  2013-11-12

2.  Age distribution and types of breast lesions among Afghan women diagnosed by fine needle aspiration cytology (FNAC) at a tertiary care centre in Afghanistan: a descriptive cross-sectional study.

Authors:  Ramin Saadaat; Jamshid Abdul-Ghafar; Ahmed Maseh Haidary; Soma Rahmani; Nooria Atta
Journal:  BMJ Open       Date:  2020-09-01       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.